All News

audience learn

EULAR 2021 - Day 3 Report

d Jack Cush, MD

Here are a few notable presentations from this past Friday, Day 3 of the EULAR 2021 virtual meeting.

Read Article
PSA068.jpg

Novel TYK2 Inhibitor Efficacious for Treatment of Psoriatic Arthritis

d Meral K. El Ramahi, MD, FACP, FACR

Dr. Philip Mease et al presented results of a phase II trial (OP0227) at EULAR 2021 that shows the efficacy and safety of an oral tyrosine kinase inhibitor (TYKi), deucravacitinib, for treatment of active psoriatic arthritis (PsA).

Read Article
unhappy%20patient.jpg

How do we personalize psoriatic arthritis treatment?

d Robert Chao, MD

It seems like every conference we are presented with data on the newest biologic for treatment of psoriatic arthritis, but the question is, do we need it?

Read Article
COVID vaccine vials

Israel provides COVID vaccine answers for rheumatic disease patients

d David Liew, FRACP

The question as to how autoimmune rheumatic disease patients fare with the COVID vaccine is one being asked in rheumatologists’ offices everywhere this year, and at the EULAR 2021 Virtual Congress, data presented from Israel, one of the first countries to vaccinate on a br

Read Article
joint.wrist_.pain_.CTS_.Carpal.jpg

RA after 70: Too Old for bioDMARDs?

d Aurelie Najm, MD, PhD

In RA, the two most common peaks of incidence are thirties and fifties; however a significant percentage of patients above the age of 70 present with active RA -of early or later onset- and require adapted treatment.

Read Article
Video: What Kind of Diet Should You be on? with Dr. Robert Chao ( @doctorRBC) https://t.co/jqkA8vrgww #EULAR2021 https://t.co/5mPuZWmw20

Links:

Dr. John Cush RheumNow ( View Tweet)
Video: Nr-axSpA vs axSpA — does it matter? Dr. Meral El Ramahi (@MeralElRamahiMD ) #EULAR2021 https://t.co/ocyR4ka8zO https://t.co/DxHjM0stKo

Links:

Dr. John Cush RheumNow ( View Tweet)
#EULAR2021 - Day 3 Report https://t.co/X7zxsKW8eL https://t.co/OKu5Mgodlo

Links:

Dr. John Cush RheumNow ( View Tweet)
Find all your AS/Spondyloarthritis coverage from #EULAR2021 in one spot. https://t.co/owm8LQzHXr https://t.co/5YmDFOvolF

Links:

Dr. John Cush RheumNow ( View Tweet)
Video: RA and Cancer: Myth or Reality? Dr. Jonathan Kay ( @RheumKay ) Dr. Kay reviewed highlights from the "Oncorheumatology: the crossroads of cancer and musculoskeletal diseases" scientific session including abstract OP0187, presented at #EULAR2021. https://t.co/KaLEZ67L5S https://t.co/6MHXyffO2W

Links:

Dr. John Cush RheumNow ( View Tweet)
Video: The Future of Treatment of RA-ILD: Dr. David Liew ( @drdavidliew ) Dr. David Liew reviews abstract OP0124 presented at #EULAR2021 https://t.co/0dqBPRiwjA https://t.co/XR7cQhPVRw

Links:

Dr. John Cush RheumNow ( View Tweet)
Video: IFN Scores Predict Resistance to Skin Disease During RTX Therapy in Lupus Dr. Yuz Yusof speaks with Dr. Lucy Carter about abstract OP0134, presented at the virtual #EULAR2021 meeting. https://t.co/pqr8uRBiRG https://t.co/lhvuYIfI34

Links:

Dr. John Cush RheumNow ( View Tweet)
What's your #EULAR2021 IQ? Answer correctly and climb the leaderboard. https://t.co/MsI3IFFdqn https://t.co/zJ1an40Yyj

Links:

Dr. John Cush RheumNow ( View Tweet)
Video: Prevalence of Long Term HCQ in Retinal Toxicity: Dr. Kathryn Dao (@KDAO2011 ) Dr. Kathryn Dao reviews abstract OP0133, "The Prevalence and Risk Factors of Retinal Toxicity Associated with Long-Term Hydroxychloroquine Use", presented at #EULAR2021. https://t.co/tZyXQhZgLG https://t.co/x6AfItFWEU

Links:

Dr. John Cush RheumNow ( View Tweet)
Tune in to our latest podcast on #EULAR2021 and EULAR IQ. https://t.co/yjId7QNRRR https://t.co/F46FLEilRY

Links:

Dr. John Cush RheumNow ( View Tweet)
#EULAR2021 IL-23 & IL-12/23 coverage in one spot on RheumNow. https://t.co/sut3zubcow https://t.co/f7XDuRyLB9

Links:

Dr. John Cush RheumNow ( View Tweet)
RA after 70: Too Old for bioDMARDs? by Dr. Aurelie Najm #EULAR2021 In RA, the two most common peaks of incidence are 30s and 50s; however a significant % of patients in 70s present with active RA -of early or later onset- and require adapted treatment. https://t.co/w6rxT0FmlP https://t.co/fnvSQcu0Fl

Links:

Dr. John Cush RheumNow ( View Tweet)
Video: Difficult to Treat RA: Look out for Comorbidities: Dr. Aurelie Najm #EULAR2021 https://t.co/71Kx0HmmDm https://t.co/iu2p2EXNof

Links:

Dr. John Cush RheumNow ( View Tweet)
@IainBMcInnes1 @NEJM @JWatch @NEJMres360 #rheumatology #rheumtwitter #MedTwitter #VisualAbstract #WorldASDay #spondyloarthritis #psoriasis #psoriaticarhtritis #MedEd #dermatology #JAKi #EBM https://t.co/dGRi83Wt9x https://t.co/22WacHQZpT

Links:

EnvisionRheumat ERheumat ( View Tweet)
OP0140 at #EULAR2021: ➡️Obs, prospect Nordic study characterized axSpA pts w/ high BASDAI + ASDAS & multiple bDMARD use (indicating difficult to tx dz) ➡️1 in 10 received at least 3 bDMARDs *⃣Multiple switchers were more often F, had higher b/l dz activity, & psoriasis @Rheumnow https://t.co/syq0szVWKe
Meral K. El Ramahi, MD MeralElRamahiMD ( View Tweet)
×